Trade Summary

3 days ago, Myers Michael, serving as Chief Executive Officer at Quoin Pharmaceuticals, Ltd. (QNRX), purchased 20,490 shares at $4.88 per share, for a total transaction value of $99,991.20. Following this transaction, Myers Michael now holds 37,713 shares of QNRX.

This purchase represents a 118.97% increase in Myers Michael's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 (accepted Sep 1, 9:39 PM ET), 2 days after the trade was made.

Quoin Pharmaceuticals, Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.